From: Comparing the cost effectiveness of harm reduction strategies: a case study of the Ukraine
a) Grant data Summary | |||||||
 | Intervention | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total |
Ukraine | harm reduction_syringe | 522,600 | 1,372,411 | 1,901,061 | 1,900,411 | 1,951,061 | 7,647,544 |
 | Substitution therapy | 1,127,125 | 1,443,544 | 3,099,845 | 3,194,531 | 3,395,208 | 12,260,253 |
b) Cost per cycle | |||||||
Cost per 1Â cycle | NSP | OST | Combined | ||||
Starting up cost | 99750.73 | 58337.55 | 14023.91 | ||||
Cost per patient | 2.52 | 29.20 | 31.72 | ||||
Total cost per 1Â cycle | Â | Â | |||||
Cost per patient | 11.59 | 40.87 | 34.06 |